- AU$21.37m
- AU$33.79m
- AU$15.12m
- 14
- 54
- 52
- 36
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.78 | ||
| Price to Tang. Book | 3.44 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.52 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -37.91% | ||
| Return on Equity | -73.56% | ||
| Operating Margin | -41.59% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 15.79 | 12.33 | 18.36 | 15.46 | 15.12 | n/a | n/a | -3.77% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Carbonxt Group Limited is a cleantech company. It develops and markets specialized activated carbon products, focused on the capture of contaminants in industrial processes that emit substantial amounts of harmful pollutants. It specializes in providing oxidizing, non-brominated activated carbons that are non-corrosive and maintain maximum efficiency, eliminating the gradual deterioration caused by highly brominated carbons without sacrificing effectiveness. It produces and manufactures powdered activated carbon and activated carbon pellets for use in industrial air purification, wastewater treatment and other liquid and gas phase markets. Its products include CXT-MATS-PAC, CXT-MATS-PAC, CXT-MATS-PAC-B, CXT-NAQ-ACP, CEM-PAC, CEM-PAC Plus, MACT-PAC, and CXT-BB500. Its MATS-PAC is a non-halogenated, oxidizing powdered activated carbon that is chemically and physically enhanced for in-flight gas phase removal of mercury. Its Cxt-NAQ-ACP is a pelletized activated carbon sorbent.
Directors
- Matthew Driscoll NEC
- Rebecca Prince CFO
- Regina Rodriguez COO
- Curt Larson VPR
- Warren Murphy MDR
- David Mazyck EDR
- Dennis Baranik OTH
- Jack Drwiega OTH
- Adrian Figueroa OTH
- Christine Valcarce OTH
- Laura Newell SEC
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 25th, 2001
- Public Since
- January 23rd, 2018
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 388,484,143
- Address
- 3951 NW 48th Terrace, Suite 111, GAINESVILLE, 32606
- Web
- https://www.carbonxt.com/
- Phone
- +1 3523784950
- Auditors
- Ernst & Young
Upcoming Events for CG1
Similar to CG1
Agrimin
Australian Stock Exchange - SEATS
Aguia Resources
Australian Stock Exchange - SEATS
Alexium International
Australian Stock Exchange - SEATS
Alpha HPA
Australian Stock Exchange - SEATS
Bio-Gene Technology
Australian Stock Exchange - SEATS
FAQ
What is the Carbonxt share price?
As of Today at 19:48 UTC, shares in Carbonxt are trading at AU$0.06. This share price information is delayed by 15 minutes.
How has the Carbonxt share price performed this year?
Shares in Carbonxt last closed at AU$0.06 and the price had moved by -23.61% over the past 365 days. In terms of relative price strength the Carbonxt share price has underperformed the ASX All Ordinaries Index by -24.78% over the past year.
What are the analyst and broker recommendations for Carbonxt?
The overall consensus recommendation for Carbonxt is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Carbonxt dividend yield?
Carbonxt does not currently pay a dividend.
Does Carbonxt pay a dividend?
Carbonxt does not currently pay a dividend.
When does Carbonxt next pay dividends?
Carbonxt does not currently pay a dividend.
How do I buy Carbonxt shares?
To buy shares in Carbonxt you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Carbonxt?
As of the previous close price of AU$0.06, shares in Carbonxt had a market capitalisation of AU$21.37m.
Where are Carbonxt shares listed?
Here are the trading details for Carbonxt:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: CG1
What kind of share is Carbonxt?
Based on an overall assessment of its quality, value and momentum Carbonxt is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Carbonxt share price forecast for 2025?
The analyst consensus target price for shares in Carbonxt is AU$0.70. That is 1172.73% above the last closing price of AU$0.06.
Analysts covering Carbonxt currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Carbonxt share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Carbonxt. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -14.5%.
As of the last closing price of AU$0.06, shares in Carbonxt were trading -17.85% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Carbonxt PE Ratio?
The Carbonxt PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Carbonxt?
Carbonxt's management team is headed by:
- Matthew Driscoll - NEC
- Rebecca Prince - CFO
- Regina Rodriguez - COO
- Curt Larson - VPR
- Warren Murphy - MDR
- David Mazyck - EDR
- Dennis Baranik - OTH
- Jack Drwiega - OTH
- Adrian Figueroa - OTH
- Christine Valcarce - OTH
- Laura Newell - SEC